Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neuroendocrine Tumors × belinostat × Clear all

Sponsor

Conditions

Fallopian Tube Neoplasms 3 Ovarian Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Carcinoma, Ovarian Epithelial 2 Urinary Bladder Neoplasms 1 Thymoma 1 Solitary Fibrous Tumor, Pleural 1 Sarcoma 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Myelodysplastic Syndromes 1 Mesothelioma, Malignant 1 Mediastinal Neoplasms 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Liver Diseases 1 Leukemia-Lymphoma, Adult T-Cell 1 Congenital Abnormalities 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1 Brenner Tumor 1

Interventions

Everolimus 13 Octreotide 6 Magnetic Resonance Spectroscopy 5 lanreotide 4 Sunitinib 4 gallium Ga 68 dotatate 3 cabozantinib 3 arginyllysine 3 Specimen Handling 3 Nivolumab 3 Etoposide 3 Carboplatin 3 Bevacizumab 3 telotristat ethyl 2 surufatinib 2 pembrolizumab 2 pazopanib 2 pasireotide 2 lutetium Lu 177 dotatate 2 X-Rays 2 Temozolomide 2 Phantoms, Imaging 2 Oxaliplatin 2 Ipilimumab 2 Erlotinib Hydrochloride 2 Doxorubicin 2 Cisplatin 2 Capecitabine 2 3-Iodobenzylguanidine 2 177Lu-DOTA-JR11 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡